Sang-Woo Lee

Sang-Woo Lee

Director/Board Member at Geneos Therapeutics, Inc.

71 connections
Finance
Health Technology

Profile

Sang-Woo Lee currently works at Korea Investment Partners Co., Ltd., as Managing Director and Geneos Therapeutics, Inc., as Director from 2021.

Sang-Woo Lee active positions

CompaniesPositionStart
Korea Investment Partners Co., Ltd.
Logo Korea Investment Partners Co., Ltd.

Korea Investment Partners Co., Ltd.

Investment ManagersFinance

Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul.

 Private Equity Investor 2014-04-13
Geneos Therapeutics, Inc.
Logo Geneos Therapeutics, Inc.

Geneos Therapeutics, Inc.

BiotechnologyHealth Technology

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

 Director/Board Member 2021-03-02
All active positions of Sang-Woo Lee

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sang-Woo Lee's experience

Connections

71

1st degree connections

2

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2
Korea Investment Partners Co., Ltd.
Logo Korea Investment Partners Co., Ltd.

Korea Investment Partners Co., Ltd.

Investment ManagersFinance

Korea Investment Partners Co., Ltd(Korea Investment Partners). is a Private Equity/Venture Capital firm, a subsidiary of Korea Investment Holdings Co., Ltd. founded in 1986. Korea Investment Partners Co., Ltd. is headquartered in Seoul.

Finance

Geneos Therapeutics, Inc.
Logo Geneos Therapeutics, Inc.

Geneos Therapeutics, Inc.

BiotechnologyHealth Technology

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Sang-Woo Lee